INDEPENDENT INTELLIGENCE
LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Aura Biosciences, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERAURA
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / AURA COVERAGE

What’s moving Aura Biosciences, Inc. now

Current reporting with the operating signal separated from the noise.

01
Aura Biosciences, Inc (AURA) Virtual Urologic Oncology Investor Event Call (Transcript)

Aura Biosciences, Inc (AURA) Virtual Urologic Oncology Investor Event Call (Transcript)

The story matters when it changes Aura Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest AURA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-11 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-08 · Period 2026-07-03SEC ↗8-KMaterial company eventFiled 2026-06-11 · Period 2026-06-11SEC ↗8-KMaterial company eventFiled 2026-05-11 · Period 2026-05-11SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-06-29 · Period 2026-08-05SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-07-27SEC ↗
EARNINGS / QUARTERLY TRACKER

Aura Biosciences, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.